Adult eczema prevalence and associations with asthma and other health and demographic factors: A US population-based study, J Allergy Clin Immunol, vol.132, issue.5, pp.1132-1140, 2013. ,
Persistence of atopic dermatitis (AD): A systematic review and meta-analysis, J Am Acad Dermatol, vol.75, issue.4, pp.681-687, 2016. ,
,
Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients, J Eur Acad Dermatol Venereol, vol.30, issue.5, pp.729-776, 2016. ,
Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey, J Am Acad Dermatol, 2017. ,
,
, Methotrexate Versus Cyclosporine in Adults with Moderate-to-Severe Atopic Dermatitis: A Phase III Randomized Noninferiority Trial, J Allergy Clin Immunol Pract, 2017.
Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt, Eur J Pediatr, vol.172, issue.3, pp.351-357, 2013. ,
Long-term Use of Systemic Treatments for Moderate-to-Severe Atopic Dermatitis in Adults: A Monocentric Retrospective Study, Acta Derm Venereol, vol.96, issue.6, pp.802-808, 2016. ,
Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres, 13. van den Reek JMPA, vol.29, pp.1-5, 2015. ,
Drug survival of biologic therapy in a large, disease-based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR), J Eur Acad Dermatol Venereol, vol.30, issue.7, pp.1621-1628, 2015. ,
,
, Monocentric Retrospective Cohort of Patients with Severe Atopic Dermatitis Treated with Cyclosporine A in Daily Practice, Acta Derm Venereol, vol.97, issue.8, pp.955-961, 2017.
Drug survival for methotrexate in a daily practice cohort of adult patients with severe atopic dermatitis, Br J Dermatol, vol.174, issue.1, pp.201-204, 2016. ,
A metaanalysis and morphological review of cyclosporine-induced nephrotoxicity in auto-immune diseases, Kidney Int, vol.54, issue.2, pp.536-581, 1998. ,
Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study, J Invest Dermatol, vol.120, issue.2, pp.211-217, 2003. ,
Cyclosporin in atopic dermatitis: time to relapse and effect of intermittent therapy, Br J Dermatol, vol.132, issue.1, pp.106-112, 1995. ,
Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy, Br J Dermatol ,
When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council, J Am Acad Dermatol, vol.77, issue.4, pp.623-656, 2017. ,
Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME), Br J Dermatol, vol.171, issue.6, pp.1318-1343, 2014. ,